Targeted Alpha Therapies: The Next Frontier in the Oncology Pipeline
The clinical pipeline for radiopharmaceuticals is undergoing a radical evolution. While the first wave of commercial success relied heavily on beta-emitting isotopes, researchers and biotech innovators are increasingly pivoting toward…